https://clinicaltrials.gov/ct2/show/NCT04762758
Phase 3
A Study to Assess the Efficacy and Safety of PXT3003 in Charcot-Marie-Tooth Type 1A
https://clinicaltrials.gov/ct2/show/NCT05092841
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT) (PLEO-CMT) [Completed]
https://clinicaltrials.gov/ct2/show/NCT02579759
https://clinicaltrials.gov/ct2/show/NCT02579759?recrs=abdef&type=Intr&cond=Charcot-Marie-Tooth&rank=10
>>> completed
Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A (PLEO-CMT-FU)
https://clinicaltrials.gov/ct2/show/NCT03023540
